Introducing the 3Dimensions Digital Mammography System
Reveal fine details with the fastest, highest resolution 3D Mammography™ exam,1 using our advanced detector and innovative 3D™ imaging technologies that help to detect more invasive cancers with confidence. With the integration of additional AI-powered solutions, the 3Dimensions is a smart, comprehensive platform supporting breast cancer detection, workflow optimisation and risk assessment.
No Compromise. No Comparison.
Combine the clinically proven cancer detection performance with a leap in personalised patient care. The Hologic® 3D Mammography™ system delivers all the benefits of high resolution imaging, while transforming how women experience their breast scan.2
Improved Detection
Tomosynthesis results that are proven to help you detect up to 65% more invasive breast cancers than 2D alone.3,**
Risk Assessment
The Hologic 3D Mammography exam was the first FDA-approved digital breast tomosynthesis system* showing superiority for women with dense breasts compared to 2D alone.4-9
Clinical Confidence
Proven technology, with over 200 studies demonstrating the exam’s clinical efficacy, giving you confidence in your everyday practice.2
Patient Comfort
Clinically proven to deliver a more comfortable mammogram experience.10
Unlock the Advantage of Time
The Breast Health Continuum of Care offers integrated solutions for clinical confidence, workflow efficiency and compassionate patient care. It gives more women, more time in better health.
The 3Dimensions Digital Mammography System is part of the Hologic Screening & Diagnosis Solution.
Proof, Not Promises
Hologic’s 3D Mammography innovative technology provides exam results that are more accurate than 2D mammography alone3,** and is proven to be more comfortable.10,** It's a technology that delivers more confidence in breast cancer detection for you, and better care for your patients.
3.7s scan time
the industry’s fastest tomosynthesis scan1,5
40% reduction
in recalls compared to 2D alone3,11,12
9000+ installed
tomosynthesis systems around the world, and counting
Sharper, Smarter, Simpler Imaging
The 3Dimensions mammography system works with the ultimate smart tomosynthesis technology, combining Clarity HD™ high resolution imaging, Intelligent 2D™ synthesised imaging and 3DQuorum™ SmartSlices for an efficient workflow.
Visit Our Virtual Hospital
Browse our portfolio of Breast Health solutions in 3D. See how you can unlock the advantage of time across the entire Breast Continuum of Care.
Multiple Improvements Available
Faster Exam, Less Compression Time
With Clarity HD high-resolution 3D imaging, our advanced detector and innovative 3D Mammography imaging algorithm work together to deliver you clear images, regardless of breast size or density.6
High Resolution at a Low Dose
Intelligent 2D AI powered Imaging Technology can help you detect more fine calcifications compared to FFDM, at a low dose.13,14
Improved Breast Comfort
The SmartCurve Breast Stabilization System is proven to help you improve comfort for your patients who experience discomfort during standard compression.10
Improved Breast Access
Smart positioning improves breast access and provides you with a smoother work flow.
Biopsy Capabilities
With Affirm® Upright and Clarity HD high-resolution 3D imaging, you can perform quick breast biopsies and pinpoint subtle lesions.
Easy Manual Decompression
Manually decompress the breast more easily while positioning the patient, with less strain on the wrist.
Ergonomic Design
Optimised stationary gantry controls improve ergonomics and workflow for technologists.
Enhanced Focus
Extending the field light during biopsy procedures helps you enhance the focus on the patient.
Clinical Images
Video Gallery
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
*Compared to other standard models.
**Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions ® on screening outcomes. Individual results may vary. The study found an average 41% (95% CI: 20-65%) increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography™ System versus women receiving 2D FFDM mammograms only.
1. Rocha Garcia, A.M., Mera Fernandez, D. Breast tomosynthesis: State of the art. Radiologia. 2019;61(4):274-285
2. Tomosynthesis Bibliography: (PDF) 3D Mammography™ Bibliography - Hologic Education (Accessed Nov 2022)
3. Friedewald SM., Rafferty EA, Rose SL., et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.
4. FDA. DBT systems digital accreditation. Available at: https://www.fda.gov/radiation-emitting-products/facility-certification-and-inspection-mqsa/digital-accreditation (last accessed 12 May 2022)
5. Lai Y-C, Ray KM, Mainprize JG, et al. Digital Breast Tomosynthesis: Technique and Common Artifacts. Journal of Breast Imaging 2020;2:615-28.
6. Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr 26;315(16):1784-6. doi: 10.1001/jama.2016.1708. PMID: 27115381
7. Mariscotti G, Durando M, Martincich L, et al. Comparative Study with Digital Mammography (DM) vs. DM Combined with Digital Breast Tomosynthesis (DBT) for the Detection of Invasive Lobular Carcinoma (ILC). RSNA 2013 Abstract SSE02-02.
8. Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-1113. doi: 10.1016/S1470-2045(16)30101-2. Epub 2016 Jun 23. PMID: 27345635.
9. Gilbert FJ, Tucker L, Gillan MGC, et al.Accuracy of Digital Breast Tomosynthesis for Depicting Breast Cancer Subgroups in a UK Retrospective Reading Study (TOMMY Trial). Radiology 2015;277:697-706.
10. Data On File: DHM-06039 Rev 002
11. Rose SL, Tidwell AL., Bujnoch LJ., et al. Implementation of breast tomosynthesis in a routine screening practice: an observational study. AJR AmJ Roentgenol. 2013;200(6):1401-1408
12. Haas BM., Kalra V., Geisel J., et al. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 2013;269:694-700.
13. Hooley RJ., Durand MA., Philpotts LE., et al. Advances in Digital Breast Tomosynthesis. AJR 2017;208:256-266
14. Zuckerman SP., Conant EF., Keller BM., et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology 2016;281:730-737.
Safety Data Sheets
Package Inserts
2797
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable